Cytotoxic effects of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine in cross-resistant H9 human lymphoma cells

Leukemia Research

Volumn 29, Issue 7, 2005, Pages 785-791

  Saiko, Philipp ^a   Horvath, Zsuzsanna ^a   Illmer, Christoph ^a   Madlener, Sibylle ^a   Bauer, Wolfgang ^a   Hoechtl, Thomas ^a   Erlach, Natascha ^b   Grusch, Michael ^b   Krupitza, Georg ^a   Mader, Robert M ^a   Jaeger, Walter ^c   Schott, Herbert ^d   Agarwal, Ram P ^e   Fritzer Szekeres, Monika ^a   Szekeres, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

5 Fluorodeoxyuridine; Apoptosis; Arabinofuranosylcytosine; Cell cycle; Cross resistance; Lymphoma

Indexed keywords

CYTARABINE; FLOXURIDINE;

APOPTOSIS; ARTICLE; CELL CYCLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; LYMPHOMA CELL; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CYTARABINE; DIMERIZATION; FLOXURIDINE; HUMANS; LYMPHOMA; PHOSPHORYLATION;

EID: 20344381786     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.12.015     Document Type: Article

References (27)

1. A.R. Kinsella, D. Smith, and M. Pickard Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage Br J Cancer 75 1997 935 945
2. J.L. Fischel, P. Formento, M.C. Etienne, T. Spector, N. Renee, and G. Milano Dual modulation of 5-fluorouracil cytotoxicity using folinic acid with a dihydropyrimidine dehydrogenase inhibitor Biochem Pharmacol 53 1997 1703 1709
3. R.L. Momparler A model for the chemotherapy of acute leukemia with 1-β-d-arabinofuranosylcytosine Cancer Res 34 1967 1775 1787
4. A. Early, H.D. Preisler, H. Slocum, and Y.M. Rustum A pilot study of high dose 1-β-arabinofuranosylcytosine for acute leukemia and refractory lymphoma Cancer Res 42 1982 1587 1594
5. N.R. Cozzarelli The mechanism of action of inhibitors of DNA synthesis Annu Rev Biochem 46 1977 641 668
6. R.M. Cattaneo-Pangrazzi, H. Schott, H. Wunderli-Allenspach, M. Derighetti, and R.A. Schwendener Induction of cell cycle-dependent cytotoxicity and apoptosis by new heterodinucleoside phosphate dimers of 5-fluorodeoxyuridine in PC-3 human prostate cancer cells Biochem Pharmacol 60 2000 1887 1896
7. R.M. Cattaneo-Pangrazzi, H. Schott, and R.A. Schwendener The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145 Prostate 45 2000 8 18
8. N. Kemeny, J.A. Conti, and A. Cohen Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma J Clin Oncol 12 1994 2288 2295
9. N. Kemeny, Y. Huang, and A.M. Cohen Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer N Engl J Med 341 1999 2039 2048
10. R.P. Agarwal, T. Han, and M. Fernandez Reduced cellular transport and activation of fluoropyrimidine nucleosides and resistance in human lymphocytic cell lines selected for arabinosylcytosine resistance Biochem Pharmacol 61 2001 39 47
11. M. Fernandez, T. Han, P. Yo, W. Wang, and R.P. Agarwal Comparison of arabinosylcytosine and dideoxycytidine induced drug resistance in H9 cells Proc Am Assoc Cancer Res 40 1999 676
12. Van Laar JAM, J.M. Rustum, S.P. Ackland, C.J. Van Groeningen, and G.J. Peters Comparison of 5-fluoro-2′-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer Eur J Cancer 34 1997 296 306
13. W.B. Parker, and Y.C. Cheng Metabolism and mechanism of action of 5-fluorouracil Pharmacol Ther 48 1990 381 395
14. R.J. Langenbach, P.V. Danenberg, and C. Heidelberg Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2′-deoxyuridylate Biochim Biophys Acta 473 1977 73 92
15. M. Inaba, Y. Naoe, and J. Mitsuhasi Mechanism for 5-fluorouracil resistance in human colon cancer DLD-1 cells Biol Pharm Bull 21 1998 569 573
16. J.J. Furth, and S.S. Cohen Inhibition of mammalian DNA polymerase by the 5′-triphosphate of 1-β-D-arabinofuranosylcytosine and the 5′-triphosphate of 9-β-D-arabinofuranosyladenine Cancer Res 28 1968 2061 2067
17. D. Kufe, P.P. Major, E.M. Egan, and G.P. Beardsley Correlation of cytotoxicity with incorporation of ara-C into DNA J Biol Chem 255 1980 8997 9000
18. T. Aas, A.L. Borresen, and S. Geisler Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients Nat Med 2 1996 811 814
19. F. Vikhanskaya, S. Vignati, and P. Beccaglia Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis Exp Cell Res 241 1998 96 101
20. D.A. Carson, and J.M. Ribeiro Apoptosis and disease Lancet 341 1993 1251 1254
21. D.E. Fisher Apoptosis in cancer therapy: crossing the threshold Cell 78 1994 539 542
22. J.A. Hickman Apoptosis induced by anticancer drugs Cancer Metastasis Rev 11 1992 121 139
23. A. Eastman Activation of programmed cell death by anticancer agents: cisplatin as a model system Cancer Cells 2 1990 275 280
24. H. Sommer, and D.V. Santi Purification and amino acid analysis of an active site peptide from thymidylate synthetase containing covalently bound 5-fluoro-2′-deoxyuridylate and methylenetetrahydrofolate Biochem Biophys Res Commun 57 1974 689 695
25. Y.C. Cheng, and K. Nakayama Effects of 5-fluoro-2′-deoxyuridine on DNA metabolism in HeLa cells Mol Pharmacol 23 1983 171 174
26. R.J. Fram, and D.W. Kufe Effect of 1-β-D-arabinofuranosylcytosine and hydroxyurea on the repair of X-ray-induced DNA single-strand breaks in human leukemic blasts Biochem Pharmacol 34 1985 2557 2560
27. A.M. Bergman, C.M. Kuiper, and D.A. Voorn Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines Biochem Pharmacol 67 2004 503 511